Three Ennature Bio Pharma directors resign during India Glycols merger
Three Ennature Bio Pharma directors resign during India Glycols merger. This raises governance concerns amid ongoing consolidation. The move may signal internal shifts affecting merger momentum. Investors should monitor developments closely for integration risks.
📊 STOCKS: ENBIO, INDIAGLYCO | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Merger
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.